Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
LifeMD, Inc. is a direct-to-patient telehealth and virtual healthcare company operating primarily in the digital health and telemedicine industry. The company provides subscription-based and episodic healthcare services through a network of affiliated medical professionals, leveraging a vertically integrated technology platform. LifeMD’s offerings span primary care, chronic condition management, men’s health, dermatology, and weight management, with a growing emphasis on long-term patient relationships rather than one-time consultations.
The company generates revenue primarily through recurring subscriptions, consultation fees, and medication fulfillment programs. LifeMD is positioned as a consumer-centric healthcare provider, combining proprietary telehealth technology, digital marketing capabilities, and integrated clinical workflows. Founded in 2016 as Conversion Labs, Inc., the company initially focused on direct-to-consumer health products before pivoting toward virtual care. It rebranded as LifeMD, Inc. in 2021 to reflect its broader healthcare platform strategy and subsequently expanded through acquisitions and internal service launches.
Business Operations
LifeMD operates through several branded healthcare platforms that collectively form its core business. Key operating brands include LifeMD Primary Care, Rex MD, Shapiro MD, and LifeMD Weight Management, each targeting distinct patient needs while sharing centralized technology, compliance, and clinical infrastructure. Revenue is generated through monthly subscriptions, visit-based fees, and prescription programs facilitated via third-party pharmacies and logistics partners.
Operations are primarily U.S.-based, with licensed medical providers delivering care across multiple states subject to regulatory approval. The company controls proprietary patient acquisition technology, data-driven marketing systems, and telehealth software, which are central to its operating model. LifeMD does not manufacture pharmaceuticals; instead, it partners with accredited pharmacies and healthcare providers to deliver treatment, maintaining an asset-light structure while emphasizing scalability and regulatory compliance.
Strategic Position & Investments
LifeMD’s strategy centers on expanding lifetime patient value by transitioning customers from single-condition treatments into comprehensive virtual primary care relationships. Growth initiatives include expanding insurance-accepted services, increasing access to chronic care management, and integrating emerging therapies such as GLP‑1–based weight management programs where clinically appropriate.
The company has pursued growth through targeted acquisitions, including Rex MD and Shapiro MD, which strengthened its presence in men’s health and dermatology. Investment priorities focus on platform development, clinical staffing, and regulatory expansion rather than large capital-intensive assets. LifeMD has publicly emphasized disciplined capital allocation and organic growth supported by technology enhancements and brand consolidation. Data inconclusive based on available public sources regarding material joint ventures outside wholly owned subsidiaries.
Geographic Footprint
LifeMD is headquartered in the United States, with corporate offices in New York and operational teams distributed across multiple states. Its services are delivered nationally through a network of licensed healthcare providers, allowing the company to reach patients in a majority of U.S. jurisdictions, subject to state-by-state medical regulations.
The company does not report significant physical operations outside the United States, and international revenue appears immaterial based on publicly available disclosures. However, its digital delivery model provides operational flexibility should regulatory frameworks permit future international expansion. Current market presence is concentrated entirely in North America.
Leadership & Governance
LifeMD was founded by Justin Schreiber, who continues to shape the company’s strategic vision with a focus on technology-enabled healthcare access and sustainable unit economics. Leadership emphasizes consumer experience, regulatory compliance, and scalable care delivery through integrated platforms.
Key executives include:
- Justin Schreiber – Chief Executive Officer and Chairman
- Ben Roth – Chief Financial Officer
- Dr. Gregory Gade – Chief Medical Officer
The board and management team collectively bring experience in digital marketing, healthcare delivery, finance, and compliance. Data inconclusive based on available public sources regarding additional executive appointments or recent leadership changes beyond those listed.